Compositions and methods of using proislet peptides and analogs thereof
AssigneeCure DM Group Holdings, LLC
InventorsClaresa S. Levetan, Victor M. Garsky, Loraine V. Upham
Life of this patent
Estimating the term…
Abstract
Embodiments relate to proislet peptides, preferably HIP, that exhibit increased stability and efficacy, and methods of using the same to treating a pathology associated with impaired pancreatic function, including type 1 and type 2 diabetes and symptoms thereof.
Claims19
A peptide consisting of the sequence of SEQ ID NO:
- 7 (HIP2B).
A pharmaceutical composition comprising a peptide consisting of the sequence of SEQ ID NO:
- 7 (HIP2B).
A method of treating type 2 diabetes in a subject in need thereof comprising administering to the subject a pharmaceutical composition comprising a peptide consisting of the sequence of SEQ ID NO:
- 7 (HIP2B).
Dependencies are inferred from the claim text.